Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
25 Feb 2025 |
About Corporate Governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
07 Feb 2025 |
On P&L |
The Company informs on some of the results expected by the market consensus
|
Download |
|
07 Nov 2024 |
On P&L |
The Company releases the press release related to the first nine months 2024 financial results
|
Download |
|
07 Nov 2024 |
On P&L |
The Company releases the first nine months 2024 financial results presentation
|
Download |
|
24 Oct 2024 |
On corporate transactions |
ROVI completes the strategic review of its CDMO business
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
09 Jan 2023 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the fourth quarter of 2022
|
Download |
|
15 Dec 2022 |
On Corporate Governance |
The Company informs about changes in the Board of Directors and the creation of an Advisory Committee.
|
Download |
|
04 Oct 2022 |
On business and financial situation |
The Company informs that it has signed a joint venture agreement with Càrniques Ceirà and Grupo Costa to construct a plant for the production of compounds of high technological value.
|
Download |
|
03 Oct 2022 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the third quarter of 2022
|
Download |
|
29 Jul 2022 |
Other relevant información |
On 26 July 2022 the public deed relating to the Company’s share capital decrease was registered with the Commercial Registry of Madrid.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
05 Oct 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: modification of transactions conducted from 11 July to 30 September 2017.
|
Download |
|
03 Oct 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted from 11 July to 30 September 2017
|
Download |
|
07 Sep 2017 |
Otros sobre negocio y situación financiera |
The Company informs that commences the enoxaparin biosimilar marketing in Germany
|
Download |
|
26 Jul 2017 |
Información sobre resultados |
ROVI releases the presentation related to the 2017 first half results
|
Download |
|
26 Jul 2017 |
Información sobre resultados |
ROVI releases the presentation related to the 2017 first half results
|
Download |
Pages
